From: Richard Kahn ‹ >
Subject: Avalanche Bio chief resigns abruptly
Sent Thursday, July 23, 2015 8:50:01 PM
To: Jeffrey E." leevacationegmail.com>
Avalanche Bio chief resigns abruptly
Jul 23 2015, 16:45 ET I About: \' alanche Biotechnologies (AAVL) I By: Douglas W. House, SA
News Editor II
• Avalanche Biotechnologics (NASDAQ:AAVL) CEO Thomas Chalberg, Ph.D., resigns
effective today. The BOD appoints SVP of Business Operations Hans Hull as interim CEO
and President. A search for a permanent successor is underway.
• Shares are off a fraction after hours.
Richard Kahn
I IBRK Associates Inc.
EFTA_R1_000351378
EFTA01743919
AI Analysis
Summarize this document or ask questions about its contents using Claude.
Typical cost: less than $0.01 per query with Haiku. Model can be changed in Settings.